# MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)

> **NCT01449032** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 60 (actual)

## Conditions studied

- Chronic Ischemic Heart Disease

## Interventions

- **BIOLOGICAL:** MSC
- **BIOLOGICAL:** Saline

## Key facts

- **NCT ID:** NCT01449032
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449032, "MesenchYmal STROMAL CELL Therapy in Patients With Chronic Myocardial Ischemia (MyStromalCell Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01449032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*